CD8A and neoplasm: In agreement with many other findings [98,99], the authors confirmed the ability of CUR to inhibit tumor cell proliferation in vitro and tumor growth in vivo, but they also found an increase in CD8+ T cells in the tumor microenvironment which correlated with delayed tumor growth [100].